Haleon PLC closed 2.53% short of its 52-week high of £4.01, which the company reached on September 18th.
Haleon PLC HLN shares slid 1.18% to £3.86 Thursday, on what proved to be an all-around rough trading session for the stock ...
KARACHI: Haleon Pakistan Limited, a consumer healthcare company, has renewed its collaboration with Smile Train, ...
Joe Amabile, a star of The Bachelorette and Bachelor in Paradise franchises, has partnered with Eroxon. This Valentine’s Day, Haleon wants to remind men that erectile dysfunction (ED) is a common ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Haleon plc (LSE/NYSE:HLN), a global consumer health leader with a market capitalization of $44 billion, disclosed today that two of its executives have acquired shares as part of the company's Share ...
The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share price of UK£3.91 suggests Haleon is potentially 25% undervalued Analyst price target for ...
Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...
Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. About Haleon ...
Microba Life Sciences (ASX:MAP), which has technology for measuring the gut microbiome, has a strategic partnership deal with pathology and radiology giant Sonic Healthcare (ASX:SHL), which acquired ...
The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity. Current share price of UK£3.91 suggests Haleon is potentially 25% underva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results